Patients on peritoneal dialysis (PD) who experience an exit-site infection (ESI) are at increased risk for peritonitis.
The condition was found in nearly 32% of hemodialysis patients, compared with only 8% and 5% of peritoneal dialysis and kidney transplant patients.
Hemodialysis and peritoneal dialysis patient experience similar amelioration in glomerular filtration rate decline.
They may differ from hemodialysis patients with respect to case mix, volume status, disease management, and routine exposure to anticoagulation.
Oral sodium bicarbonate may ease hyperphosphatemia in peritoneal dialysis (PD) patients with metabolic acidosis.
Patients initiating dialysis have a lower hospitalization risk in the first year if they start on peritoneal dialysis (PD) instead of hemodialysis (HD).
The risk is three times greater when compared with hemodialysis.
Risk of peritonitis elevated six-fold in 30 days before death in patients on treatment
ST. JOHN'S, NEWFOUNDLAND—Patients on peritoneal dialysis (PD) are at 51% higher risk of being hospitalized for infections than those receiving hemodialysis (HD), according to findings presented at the Canadian Society of Nephrology annual meeting.
Many patients start dialysis treatment with hemodialysis (HD) even though they initially had opted for peritoneal dialysis (PD), according to researchers.
PRAGUE—For patients with congestive heart failure (CHF) who initiate maintenance dialysis, those starting on peritoneal dialysis (PD) have a significantly greater death risk than those starting on hemodialysis (HD), according to a French study.
PRAGUE—End-stage renal disease patients who start on peritoneal dialysis (PD) rather than hemodialysis (HD) spend less time on a renal transplant waiting list before getting a kidney, new findings suggest.
Hemodialysis (HD) vascular access type at the time of dialysis initiation may be an important modifier that can affect overall patient survival, according to a new Canadian study.
PHOENIX—Lower serum magnesium levels are a significant predictor of mortality in patient on peritoneal dialysis (PD), researchers found.
PHOENIX—Marked hyperglycemia in diabetic patients on chronic peritoneal dialysis (CPD) are at increased risk of death, a study found.
Fungal peritonitis has a worse prognosis than bacterial peritonitis in patients on peritoneal dialysis (PD), according to a study. It is associated with higher rates of catheter removal, technique failure, and mortality.
New findings suggest that iron may have a role in the pathogenesis of calciphylaxis.
A study of risk factors associated with peritoneal dialysis (PD) catheter survival found that a non-infectious catheter-related problem was the only independent variable significantly associated with an increased risk of catheter failure.
Regulatory changes have enhanced clinicians' ability to recommend the modality, which offers long-term survival similar to that of hemodialysis.
A survey of 1,621 U.S. dialysis patients shows that although peritoneal dialysis (PD) had been discussed with 61% of those individuals, only 10.9% of the informed patients chose this dialysis method.
Patients with end-stage renal disease (ESRD) who convert to hemodialysis (HD) after failing treatment with peritoneal dialysis (PD) may be at higher death risk in the first year than ESRD patients who used HD as their primary treatment, but researchers caution that the association may not be causal.
Reasons include a lack of nephrologist training in the modality and a number of mistaken beliefs.
Compared with incident hemodialysis (HD) patients, incident peritoneal dialysis (PD) patients, especially non-diabetics, show a robust and consistent survival advantage for up to five years.
Central venous catheters are the most prevalent access type in patients who initiated hemodialysis (HD) following a failed renal transplant.
Home-based peritoneal dialysis may be less intrusive in their lives than in-center hemodialysis.
SEATTLE—A study by British investigators suggests that more older patients with end-stage renal disease (ESRD) should be educated about peritoneal dialysis (PD) and the potential benefits it may offer over hemodialysis (HD).
In an eight-week study of 15 patients, oral niacinamide added to standard phosphorus-lowering therapies resulted in a modest yet significant reduction in plasma phosphorus levels in patients on peritoneal dialysis.
SAN DIEGO—Following renal transplant failure, patients starting peritoneal dialysis (PD) have better survival in the first year than patients starting on hemodialysis (HD), but the survival advantage lessens with time, British resesarchers reported at the American Society of Nephrology's Renal Week conference.
The use of peritoneal dialysis (PD) is increasing at a faster rate in developing than in developed countries, according to what Canadian researchers say is the first comprehensive assessment of PD worldwide.
A Canadian study of 4,247 patients on peritoneal dialysis (PD) found that older age, black race, switching to PD from hemodialysis (HD), and diabetes in women were associated with a significantly increased risk of peritonitis.